Literature DB >> 8746549

Neurocognitive characteristics of individuals with resistance to thyroid hormone: comparisons with individuals with attention-deficit hyperactivity disorder.

M A Stein1, R E Weiss, S Refetoff.   

Abstract

Previous studies have demonstrated an association between resistance to thyroid hormone (RTH) and attention-deficit hyperactivity disorder (ADHD). To determine if the neurocognitive characteristics in individuals with RTH are similar to those observed in ADHD, 12 children with RTH from 7 families were matched to 12 children with ADHD without RTH. Subjects were administered standardized intellectual, developmental, and school achievement tests. Parent and teacher ratings of children's hyperactivity and attention were similar for both groups, as were measures of attention, impulsivity, and verbal IQ. Children with RTH displayed lower nonverbal intelligence (performance IQ = 85) and academic achievement (> 1-2 SD below the mean) when compared with those with ADHD only (performance IQ = 99; achievement within 2 SD). Although children with RTH have behavioral characteristics similar to those with ADHD, their significantly weaker abilities of perceptual-organization and lower school achievement suggest a more severe neurobehavioral impairment than ADHD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8746549

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  11 in total

Review 1.  Resistance to thyroid hormone.

Authors:  R E Weiss; S Refetoff
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

2.  Hyperactivity and learning deficits in transgenic mice bearing a human mutant thyroid hormone beta1 receptor gene.

Authors:  M P McDonald; R Wong; G Goldstein; B Weintraub; S Y Cheng; J N Crawley
Journal:  Learn Mem       Date:  1998 Sep-Oct       Impact factor: 2.460

Review 3.  Genetic influences in childhood-onset psychiatric disorders: autism and attention-deficit/hyperactivity disorder.

Authors:  S L Smalley
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

4.  Hyperactivity, impaired learning on a vigilance task, and a differential response to methylphenidate in the TRbetaPV knock-in mouse.

Authors:  William B Siesser; Sheue-yann Cheng; Michael P McDonald
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

Review 5.  Attention-deficit/hyperactivity disorder: a neuropsychological perspective towards DSM-V.

Authors:  Gerry A Stefanatos; Ida Sue Baron
Journal:  Neuropsychol Rev       Date:  2007-03       Impact factor: 7.444

6.  Genome-wide analysis of thyroid hormone receptors shared and specific functions in neural cells.

Authors:  Fabrice Chatonnet; Romain Guyot; Gérard Benoît; Frederic Flamant
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 7.  Immunologic and neurodevelopmental susceptibilities of autism.

Authors:  Isaac N Pessah; Richard F Seegal; Pamela J Lein; Janine LaSalle; Benjamin K Yee; Judy Van De Water; Robert F Berman
Journal:  Neurotoxicology       Date:  2008-02-23       Impact factor: 4.294

8.  Prenatal organochlorine exposure and measures of behavior in infancy using the Neonatal Behavioral Assessment Scale (NBAS).

Authors:  Sharon K Sagiv; J Kevin Nugent; T Berry Brazelton; Anna L Choi; Paige E Tolbert; Larisa M Altshul; Susan A Korrick
Journal:  Environ Health Perspect       Date:  2008-05       Impact factor: 9.031

9.  Resistance to thyroid hormone-beta co-existing with partially empty sella in a Jordanian male.

Authors:  Ohoud Al Mohareb; Mussa H AlMalki; O Thomas Mueller; Imad Brema
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-12-05

10.  Patients with mutations of the Thyroid hormone beta-receptor show an ADHD-like phenotype for performance monitoring: an electrophysiological study.

Authors:  Jan Uter; Marcus Heldmann; Berenike Rogge; Martina Obst; Julia Steinhardt; Georg Brabant; Carla Moran; Krishna Chatterjee; Thomas F Münte
Journal:  Neuroimage Clin       Date:  2020-03-19       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.